Aspire Pharma Limited

Neonatal Respiratory Disorders

Clinical research activity is centred on bronchopulmonary dysplasia, with attention to conditions affecting premature infants and early lung development.

  • Preterm infant care
  • Bronchopulmonary dysplasia
  • Immature pulmonary function

The sponsor’s trial landscape reflects interest in respiratory morbidity associated with very early birth and the clinical needs of neonatal intensive care.

Vitamin A and Retinoid Biology

Research focus includes retinol status and its role in supporting neonatal physiology, particularly in infants born at the limits of viability.

  • Retinol serum concentration
  • Vitamin A metabolism
  • Micronutrient support in neonates

Interest in retinoid biology aligns with clinical evaluation of nutrient-related factors relevant to early postnatal development.

Neonatal Safety and Tolerability

Clinical investigation also addresses safety and tolerability in a vulnerable paediatric population, with emphasis on early-life exposure monitoring.

  • Infant tolerability assessment
  • Post-menstrual age monitoring
  • Clinical safety evaluation

This area highlights therapeutic interest in treatments intended for use during the neonatal period, where physiological immaturity shapes clinical decision-making.

Perinatal and Neonatal Medicine

The sponsor’s funded research sits within perinatal medicine and neonatology, focusing on infants requiring specialist care after extremely preterm delivery.

  • Neonatal intensive care
  • Prematurity-related complications
  • Early developmental support

These interests connect clinical evaluation with conditions encountered in the earliest stages of life, especially where respiratory and nutritional factors intersect.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland